Options
Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial
Journal
The Lancet Rheumatology
Journal Volume
3
Journal Issue
2
Start Page
e122-e130
ISSN
2665-9913
Date Issued
2021-02
Author(s)
Saira Z Sheikh
Morton A Scheinberg
Dana Tegzova
William Stohl
Ricardo Acayaba de Toledo
Tamara Mucenic
Mauricio R Abello Banfi
Kathleen Maksimowicz-McKinnon
Carlos Abud-Mendoza
Sandra Navarra
Mercedes Garcia
Ignacio Garcia-De La Torre
Josep Ordi Ros
Roger A Levy
Damon L Bass
Jorge Ross Terrés
Raj Punwaney
Julia Harris
Alireza Nami
Amy Pierce
Kevin S Thorneloe
Beulah Ji
David A Roth
SDGs
Publisher
Elsevier BV
Type
journal-article